| 摘要 |
The invention relates generally to the field of delayed release dosage forms for the delivery and release of beneficial and viable bacteria to the intestine or bowel. Particularly oral dosage forms containing stabilized viable bacteria using a non-hygroscopic agent and wherein said oral composition is further characterized in being stable at lower pH, in having an accelerated dissolution profile at higher pH and in being stable during long term storage.
|
